480 Biomedical

About:

480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery.

Website: http://www.480biomedical.com

Top Investors: Polaris Partners, Broadview Ventures, North Bridge Venture Partners & Growth Equity, Intersouth Partners

Description:

480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown, Massachusetts.